Caricamento...
668. Quality of Life Changes in Patients with Clostridium difficile Infection (CDI): A Randomized, Double-Blind Trial of Ridinilazole (RDZ) Compared with Vancomycin (VAN)
BACKGROUND: C. difficile is the most frequent hospital-acquired bacteria in the United States. CDI is associated with significant morbidity and mortality, and a 46% lower mean EQ-5D index of Health-Related Quality of Life (HRQoL) compared with the general population. However, data on the impact of a...
Salvato in:
| Pubblicato in: | Open Forum Infect Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811188/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.736 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|